The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,735.00
Bid: 3,775.00
Ask: 3,790.00
Change: -50.00 (-1.32%)
Spread: 15.00 (0.397%)
Open: 3,820.00
High: 3,820.00
Low: 3,735.00
Prev. Close: 3,785.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jun 2023 07:00

RNS Number : 7720C
RHI Magnesita N.V.
15 June 2023
 

RHI Magnesita N.V.

("RHI Magnesita" the "Company" or the "Group")

TRADING UPDATE

 

RHI Magnesita, the leading global supplier of high‐grade refractory products, systems and solutions, today provides an update on trading for the five months ended 31 May 2023 (the "Period").

 

Trading update for the five months ended 31 May 2023

The momentum of improving profitability and margins delivered in Q1 2023 continued in April and May, as refractory pricing was largely maintained against a background of reducing costs.

Refractory sales volumes in the Period excluding M&A were 7% lower year on year, in line with overall market demand. Steel, cement and glass demand outside of India remains soft due to a slowdown in construction activity, with some glass project postponements now evident. Demand in the non-ferrous metals segment continues to be resilient. As anticipated due to the subdued demand backdrop and reducing input costs, the Group is beginning to experience sales price deflation in a number of its markets which is expected to continue and possibly accelerate through the remainder of the year.

Refractory EBITA margin contribution for the Period, which excludes vertical integration benefits, was better than expected, supported by cost deflation in April and May, as the cost of freight and purchased raw material reduced, partially offset by weaker fixed cost absorption due to lower production volumes.

The continued lower pricing environment for magnesite-based raw materials means that the Group's vertical integration EBITA margin contribution remains subdued and in line with the 1.8% of Group margin delivered in the second half of 2022.

As a result, the overall Adjusted EBITA margin for the Period was 12.1% (2022: 11.6%), delivering Unaudited Adjusted EBITA of €174 million (2022: €155 million).

 

Financial position

Net debt to EBITDA remains at a similar level to the 2.1x reported at 31 March 2023, including a 12 month historic contribution from businesses acquired during the period.

Absolute net debt at 31 May 2023 was largely unchanged from 31 December 2022, supported by strong operating cashflow. The Group continues to retain significant liquidity of €1.2 billion.

Net Working capital (before consolidation of M&A) was down slightly from its 31 December 2022 level, as reductions in inventory and accounts receivable were largely offset by lower accounts payable. The Group continues to prioritise security of supply for its customers in order to support recent market share gains.

Total capital expenditure in the five months to 31 May 2023 was €42 million, out of overall guidance of €200 million for 2023, with spending weighted towards the second half.

M&A increased net debt by €268 million in the first five months of the year, which was partially offset by the Qualified Institutional Placement ("QIP") by RHI Magnesita India Ltd, which raised approximately €101 million in April 2023. The QIP is to be followed by an equity investment of €22 million by the Group in RHI Magnesita India Ltd via a Preferential Issue which is expected to complete in June 2023. In the second half of the year the previously announced acquisition of Seven Refractories for a cash consideration of €95 million is expected to be completed.

 

Outlook

The outlook for the Group's key end markets and consequently customer volumes remains uncertain, with the order book currently suggesting only a moderate volume increase in H2, if at all, resulting in ongoing under-absorption of fixed costs. Pricing pressure is expected to continue and possibly accelerate through the remainder of the year.

Supported by the stronger than expected performance in the first five months of the year, the Board now expects a modest outperformance on its earlier 2023 EBITA and EBITA margin guidance.

Leverage, measured as a ratio of net debt to EBITDA, is expected to remain above 2.0x as the Group further executes on its M&A pipeline.

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel +43 699 1870 6490

E‐mail: chris.bucknall@rhimagnesita.com

 

For media enquiries:

Hudson Sandler

Tel +44 020 7796 4133

E-mail: rhimagnesita@hudsonsandler.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 13,500 employees in 33 main production sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the prime segment of the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (596/2014/EU).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKQBNDBKBCAD
Date   Source Headline
13th Aug 20196:00 pmRNSTransaction in Own Shares
13th Aug 20197:00 amRNSInterim dividend - Correction of record date
12th Aug 20196:00 pmRNSTransaction in Own Shares
12th Aug 20197:05 amRNSPurchase of own shares
12th Aug 20197:00 amRNSHalf-year Report
12th Jul 20195:35 pmRNSNotice of Results
9th Jul 201910:46 amRNSExternal Directorship
9th Jul 20197:00 amRNSResult of Secondary Placing in RHI Magnesita N.V.
8th Jul 20194:37 pmRNSProposed Secondary Placing in RHI Magnesita N.V.
6th Jun 20193:22 pmRNSResult of AGM
8th May 20197:00 amRNSQ1 2019 TRADING UPDATE
7th May 20199:29 amRNSExternal Directorship
1st May 20196:00 pmRNSTotal Voting Rights
18th Apr 201912:08 pmRNSExternal Directorship
10th Apr 201911:20 amRNSMerger Update
1st Apr 201910:37 amRNSTotal Voting Rights
27th Mar 20199:34 amRNSSecondary listing on Vienna Stock Exchange
27th Mar 20197:00 amRNSFinal Results
20th Mar 201910:04 amRNSMerger Update
6th Mar 201910:27 amRNSNotice of Results
28th Feb 20194:03 pmRNSTotal Voting Rights
21st Feb 201910:35 amRNSMerger Update
14th Feb 20196:12 pmRNSNotification of Agreement
31st Jan 20195:44 pmRNSTotal Voting Rights
25th Jan 20196:00 pmRNSRHI Magnesita
24th Jan 20197:00 amRNSCancellation of Listing
22nd Jan 201911:36 amRNSMerger Update
22nd Jan 201911:21 amRNSResignation of Director
10th Jan 201912:18 pmRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
17th Dec 201812:16 pmRNSAdditional Listing
12th Dec 20185:46 pmRNSRHI Magnesita
12th Dec 20184:45 pmRNSDirector/PDMR Shareholding
11th Dec 201812:23 pmRNSBlock Listing Application
11th Dec 20187:00 amRNSMerger Update
3rd Dec 201810:12 amRNSDirector/PDMR Shareholding
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSSite Visit Presentation
27th Nov 20185:50 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSMerger Update
5th Nov 20187:01 amRNS3rd Quarter Results
2nd Nov 201811:29 amRNSChange of Corporate Broker
21st Sep 201811:21 amRNSUpdate on position of Chief Financial Officer
16th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSNew Term Loan and Multi-currency Credit Facility
1st Aug 20189:07 amRNSNotification under Listing Rule 9.6.14R
1st Aug 20187:00 amRNSProposed merger of Indian subsidiaries
29th Jun 20182:46 pmRNSDirector/PDMR Shareholding
29th Jun 20182:43 pmRNSDirector/PDMR Shareholding
29th Jun 20182:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.